References
1 UNAIDS, “global HIV statistics fact sheet 2021,”
https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf,
Accessed 26 Nov 2021.
2 Barik SK, Bansal AK, Mohanty PS, Tripathy SP, Hanna LE,
Karunaianantham R et.al. Detection of Drug Resistance Mutations in the
Reverse Transcriptase Gene of HIV-1-Infected North Indian Population
Failing First-Line Antiretroviral Therapy ”A Follow-Up Cohort Study”.
AIDS Res Hum Retroviruses. 2021;37(10):796-805.
3 Alene M, Awoke T, Yenit MK, Tsegaye AT, Yismaw L, Yeshambel R.
Second-line antiretroviral therapy regimen change among adults living
with HIV in Amhara region: a multi-centered retrospective follow-up
study. BMC Res Notes. 2019; 12(1): 407.
4 Martinez-Vega R, De La Mata NL, Kumarasamy N, et al. Durability of
antiretroviral therapy regimens and determinants for change in
HIV-1-infected patients in the TREAT Asia HIV Observational Database
(TAHOD-LITE). Antivir Ther. 2018; 23(2): 167-78.
5 Ajose O, Mookerjee S, Mills EJ, Boulle A, Ford N. Treatment outcomes
of patients on second-line antiretroviral therapy in resource-limited
settings: a systematic review and meta-analysis. AIDS. 2012; 26(8):
929-38.
6 Edessa D, Sisay M, Asefa F. Second-line HIV treatment failure in
sub-Saharan Africa: A systematic review and meta-analysis. PloS one.
2019; 14(7): e0220159.
7 Zenebe Haftu A, Desta AA, Bezabih NM, et al. Incidence and factors
associated with treatment failure among HIV infected adolescent and
adult patients on second-line antiretroviral therapy in public hospitals
of Northern Ethiopia: Multicenter retrospective study. PloS one. 2020;
15(9): e0239191.
8 World Health Organization. Consolidated Guidelines on the Use of
Antiretroviral Drugs for Treating and Preventing HIV Infection:
Recommendations for a Public Health Approach. World Health Organization.
Geneva, Switzerland; 2013.
9
Development
of China ”Free ART Manual”
http://www.aizhi.org/UploadSoft/2005321103838886.pdf,Accessed Dec.
2021.
10 Zhang M, Shang M, Yang W, Chen J, Wang Z, Shang H. Treatment effect
and drug-resistant mutations in Chinese AIDS patients switching to
second-line antiretroviral therapy. PloS one. 2014; 9(10): e110259.
11 Chen J, Zhang M, Shang M, Yang W, Wang Z, Shang H. Research on the
treatment effects and drug resistances of long-term second-line
antiretroviral therapy among HIV-infected patients from Henan Province
in China. BMC Infect Dis. 2018; 18(1): 571.
12 Dou Z, Chen RY, Wang Z, et al. HIV-infected former plasma donors in
rural Central China: from infection to survival outcomes, 1985–2008.
PloS one. 2010; 5(10): e13737.
13 Editor Group, Handbook of China’s free ART program. 3rd ed. Beijing:
Ren Min Wei Sheng Chu ban She; 2012.
14 Liu ZB, Wang X, Liu HJ, et al. Treatment of acquired immunodeficiency
syndrome with Chinese medicine in China: opportunity, advancement and
challenges. Chin J Integr Med. 2013; 19(8): 563-7.
15 Jin YT, Guo HJ, Wang X, et al. Traditional Chinese Medicine Could
Increase the Survival of People Living with HIV in Rural Central China:
A Retrospective Cohort Study, 2004-2012. Am J Chin Med. 2014; 42(6):
1333-44.
16 Jin YT, Liu ZB, Chen XM, et al. Survival of people living with HIV
after treatment with traditional Chinese medicine in Henan province of
China: a retrospective cohort study. J Tradit Chin Med. 2014; 34(4):
430-6.
17 Zhu JR, Gao RL, Zhao PP, Lu GP, Zhao D, Li JJ. Chinese guidelines for
prevention and treatment of dyslipidemia in adults (2016
Revision)[J]. Chinese Journal of Circulation,2016,31(10):937-953.
18 Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity
associated with antiretroviral therapy in adults infected with human
immunodeficiency virus and the role of hepatitis C or B virus infection.
JAMA. 2000; 283(1): 74-80.
19 Erythrocyte diseases (anemia) Group, Hematology Branch of Chinese
Medical Association. Multidisciplinary expert consensus on the
diagnosis, treatment and prevention of iron deficiency and iron
deficiency anemia (2022 edition) [J]. Chinese medical journal,
2022102 (41): 3246-3256.
20 Cao WJ, Yao YM, Wei W, Lin F, Lu JD, Yuan Z. Survival time and
related factors on HIV/AIDS patients in Guizhou province from 1995 to
2018. Zhonghua liu xing bing xue za zhi. 2020; 41(4): 557-61.
21 Liang Y, Yang WJ, Sun DY, Li N, Wang Z. Survival analysis on Former
Plasma Donors living with HIV/AIDS after initiation of antiretroviral
therapy in Henan province, 2002-2017. Zhonghua liu xing bing xue za zhi.
2019; 40(6): 638-42.
22 Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A.
Treatment failure and mortality factors in patients receiving
second-line HIV therapy in resource-limited countries. JAMA. 2010;
304(3): 303-12.
23 Li M, Tang W, Bu K, et al. Mortality among People Living with HIV and
AIDS in China: Implications for Enhancing Linkage. Sci Rep. 2016, 6:
28005.
24 Mangal TD, Meireles MV, Pascom ARP, de Almeida Coelho R, Benzaken AS,
Hallett TB. Determinants of survival of people living with HIV/AIDS on
antiretroviral therapy in Brazil 2006-2015. BMC Infect Dis. 2019; 19(1):
206.
25 Zhu, Keying., Xu, Qianlei., Xu, Qianlei., Ma, Yanmin., Li, Pengyu..
Suboptimal immune recovery and associated factors among people living
with HIV/AIDS on second-line antiretroviral therapy in central China: A
retrospective cohort study. Journal of medical virology, 2022, .
26 Ahn MY, Jiamsakul A, Khusuwan S, et al. The influence of
age-associated comorbidities on responses to combination antiretroviral
therapy in older people living with HIV. J Int AIDS Soc. 2019; 22(2):
e25228.
27 Ross J, Jiamsakul A, Kumarasamy N, et al. Virological failure and HIV
drug resistance among adults living with HIV on second-line
antiretroviral therapy in the Asia-Pacific. HIV Med. 2021; 22(3):
201-211.
28 Lundgren JD, Mocroft A. Anemia and survival in human immunodeficiency
virus. Clin Infect Dis. 2003; 37 Suppl 4: S297–S303.
29 Santiago-Rodriguez EJ, Mayor AM, Fernandez-Santos DM, Ruiz-Candelaria
Y, Hunter-Mellado RF. Anemia in a cohort of HIV-infected Hispanics:
prevalence, associated factors and impact on one-year mortality. BMC Res
Notes. 2014; 7: 439.
30 Nigussie F, Alamer A, Mengistu Z, Tachbele E. Survival and Predictors
of Mortality Among Adult HIV/AIDS Patients Initiating Highly Active
Antiretroviral Therapy in Debre-Berhan Referral Hospital, Amhara,
Ethiopia: A Retrospective Study. HIV/AIDS. 2020; 12: 757-768.
31 Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease
in human immunodeficiency virus-infected patients. Semin Liver Dis.
2012; 32(2): 103-113.
32 Taborelli M, Suligoi B, Toffolutti F, Frova L, Grande E, Grippo F, et
al. Excess liver‐related mortality among people with AIDS compared to
the general population: an Italian nationwide cohort study using
multiple causes of death. HIV Med. 2020, 21(10): 642-9.
33 Jin YT, Wang X, Li ZB, et al. Survival of AIDS Patients Treated with
Traditional Chinese Medicine in Rural Central China: A Retrospective
Cohort Study, 2004–2012. Evid Based Complement Alternat Med. 2015,
2015: 282819.
34 Wang Y, Jin F, Wang Q, Suo Z. Long-Term Survival of AIDS Patients
Treated with Only Traditional Chinese Medicine. Altern Complement Ther.
2017; 23(2): 60-2.
35 Li X, Li H, Li C, Xia W, Li A, Li W. Traditional Chinese Medicine Can
Improve the Immune Reconstruction of HIV/AIDS Patients. AIDS Res Hum
Retroviruses. 2020; 36(4): 258-9.
36 Wang DL, Ma SN, Ma YM, Guo HJ, Li PY, Yang CL et al. Effect of
Traditional Chinese Medicine therapy on the trend in CD4+T-cell counts
among patients with HIV/AIDS treated with antiretroviral therapy: a
retrospective cohort study. Evid Based Complement Alternat Med, 2021,
5576612.